Chlormethine in refractory mycosis fungoides folliculotropa
DOI:
https://doi.org/10.35509/01239015.896Keywords:
Mycosis fungoides, lymphoma, T-cell, cutaneous, mechlorethamine, nitrogen mustard compoundsAbstract
Mycosis fungoides is the most frequent cutaneous lymphoma. Unlike classic mycosis fungoides, folliculotropic mycosis fungoides is associated with refractory treatment and poor prognosis. In Colombia, topical chlormethine has been available for only two years. We present three cases of folliculotropic mycosis fungoides resistant to topical and systemic treatments, which had an excellent response to chlormethine.
Author Biographies
Rafael Montealegre, Unidad Funcional Dermatología, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.
1. Unidad Funcional Dermatología, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.
Xavier Rueda, Unidad Funcional Dermatología, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.
1. Unidad Funcional Dermatología, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.
Juan Ospina, Unidad de Hemato Oncología, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.
2. Unidad de Hemato Oncología, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.
John Nova1, Unidad Funcional Dermatología, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.
1. Unidad Funcional Dermatología, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia.
References
Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703-14. https://doi.org/10.1182/blood.2019002852
Mitteldorf C, Stadler R, Sander CA, Kempf W. Folliculotropic mycosis fungoides. J Dtsch Dermatol Ges. 2018;16(5):543-57. https://doi.org/10.1111/ddg.13514
Ramsay DL, Meller JA, Zackheim HS. Topical treatment of early cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 1995;9(5):1031-56. PMID: 8522483.
Price NM, Hoppe RT, Deneau DG. Ointment-based mechlorethamine treatment for mycosis fungoides. Cancer. 1983;52(12):2214-9. https://doi.org/10.1002/1097-0142(19831215)52:12%3C2214::aid-cncr2820521207%3E3.0.co;2-h
Hoppe RT, Abel EA, Deneau DG, Price NM. Mycosis fungoides: management with topical nitrogen mustard. J Clin Oncol. 1987;5(11):1796-803. https://doi.org/10.1200/JCO.1987.5.11.1796
Ramsay DL, Parnes RE, Dubin N. Response of mycosis fungoides to topical chemotherapy with mechlorethamine. Arch Dermatol. 1984;120(12):1585-90. PMID: 6508330
de Quatrebarbes J, Esteve E, Bagot M, Bernard P, Beylot-Barry M, Delaunay M, et al. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study. Arch Dermatol. 2005;141(9):1117-20. https://doi.org/10.1001/archderm.141.9.1117
Lessin SR, Duvic M, Guitart J, Pandya AG, Strober BE, Olsen EA, et al. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides. JAMA Dermatol. 2013;149(1):25-32. https://doi.org/10.1001/2013.jamadermatol.541
Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome - Update 2017. Eur J Cancer. 2017;77:57-74. https://doi.org/10.1016/j.ejca.2017.02.027
Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, et al. Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29(18):2598-607. https://doi.org/10.1200/JCO.2010.32.0630
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Revista Colombiana de Cancerología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Todos los derechos reservados.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
